Cargando…
cfDNA testing for monitoring response to EGFR tyrosine kinase inhibitors: Time for clinical implementation?
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7341337/ https://www.ncbi.nlm.nih.gov/pubmed/32650267 http://dx.doi.org/10.1016/j.ebiom.2020.102886 |
| _version_ | 1783555217306943488 |
|---|---|
| author | Normanno, Nicola De Luca, Antonella Perrone, Francesco |
| author_facet | Normanno, Nicola De Luca, Antonella Perrone, Francesco |
| author_sort | Normanno, Nicola |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7341337 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Elsevier |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-73413372020-07-14 cfDNA testing for monitoring response to EGFR tyrosine kinase inhibitors: Time for clinical implementation? Normanno, Nicola De Luca, Antonella Perrone, Francesco EBioMedicine Commentary Elsevier 2020-07-07 /pmc/articles/PMC7341337/ /pubmed/32650267 http://dx.doi.org/10.1016/j.ebiom.2020.102886 Text en © 2020 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
| spellingShingle | Commentary Normanno, Nicola De Luca, Antonella Perrone, Francesco cfDNA testing for monitoring response to EGFR tyrosine kinase inhibitors: Time for clinical implementation? |
| title | cfDNA testing for monitoring response to EGFR tyrosine kinase inhibitors: Time for clinical implementation? |
| title_full | cfDNA testing for monitoring response to EGFR tyrosine kinase inhibitors: Time for clinical implementation? |
| title_fullStr | cfDNA testing for monitoring response to EGFR tyrosine kinase inhibitors: Time for clinical implementation? |
| title_full_unstemmed | cfDNA testing for monitoring response to EGFR tyrosine kinase inhibitors: Time for clinical implementation? |
| title_short | cfDNA testing for monitoring response to EGFR tyrosine kinase inhibitors: Time for clinical implementation? |
| title_sort | cfdna testing for monitoring response to egfr tyrosine kinase inhibitors: time for clinical implementation? |
| topic | Commentary |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7341337/ https://www.ncbi.nlm.nih.gov/pubmed/32650267 http://dx.doi.org/10.1016/j.ebiom.2020.102886 |
| work_keys_str_mv | AT normannonicola cfdnatestingformonitoringresponsetoegfrtyrosinekinaseinhibitorstimeforclinicalimplementation AT delucaantonella cfdnatestingformonitoringresponsetoegfrtyrosinekinaseinhibitorstimeforclinicalimplementation AT perronefrancesco cfdnatestingformonitoringresponsetoegfrtyrosinekinaseinhibitorstimeforclinicalimplementation |